Premium Health brings this unique service directly to your home
Researchers are still studying the effects of GLP-1 RAs during early pregnancy
PATIENTS with type 2 diabetes treated with glucagon-like peptide-1 receptor agonists (GLP-1 RAs) may face an increased risk of developing certain autoimmune diseases compared with those on dipeptidyl peptidase-4 inhibitors (DPP-4is), according to new real-world evidence from a large U.S
Press the dose button fully and hold for 10 seconds or until the indicator shows the dose is complete, as specified in the Patient Information Leaflet
Journal of Physiology, 589(Pt 4), 963973
Safe, reliable, cruelty-free, and suitable for all body types, it is clinically tested to deliver visible results in as little as 7 days